AU2001282066A1 - Screening method - Google Patents

Abstract

Identifying pain-regulating substances (A) comprises (i) incubating test substance with a cell (or preparation from it) that has synthesized a peptide or protein (B) and (ii) measuring either binding of test substance to (B) or some functional parameter that is altered by this binding. (B) is (i) one or more of JNK3, PIM-2, TFIIFbeta , GGT-beta , GATA3, CLC-7, catalase, tetraspanin (TM4SF/TSPAN-6/TM4D), casein kinase 1a, MAP3K7/TAK-1 (TGFbeta -activated kinase), BAB14112 and/or spemidine synthase; (ii) encoded, at least in part, by any of 31 sequences (S1), reproduced, or sequences with at least 90% similarity; (iii) any of 30 sequences (S2), reproduced, or sequences with at least 90% similarity; (iv) encoded by a sequence that binds, under stringent conditions to S1 or their antisense polynucleotides; (v) a fragment of at least 10 amino acids from any of (i)-(iv) and/or (vi) encoded by a gene which includes any of 33 specified sequences (S3), reproduced, or a gene with at least 90% similarity. Independent claims are also included for the following: (1) polynucleotide that is at least 90, best 97,% similar to S3 or a gene that includes S3; (2) polynucleotide that is at least 90, best 97,% similar to sequences obtained by screening a cDNA bank with a labeled S3 under stringent conditions or by using fragments of S3 as gene-specific primers in polymerase chain reaction (PCR), using cDNA or genomic DNA as template; (3) vector containing polynucleotides of (1) and (2); (4) peptide or protein encoded by polynucleotides of (1) and (2), or by a sequence that hybridizes under stringent conditions to S3 or their antisense polynucleotides; (5) antibody (Ab) against peptides or proteins of (4); (6) cell containing a polynucleotide of (1) and (2), peptide or protein of (4) and/or a vector of (3); (7) transgenic non-human mammal whose germ and somatic cells contain a polynucleotide of (1) and (2); (8) (A) identified by the new method; (9) active compounds (A') that bind to peptides or proteins of (4); (10) pharmaceutical composition containing polynucleotides of (1) and (2), peptides and proteins of (4), vectors of (3), Ab, cells of (6), (A) or (A'), optionally also auxiliaries and additives; (11) diagnostic composition containing polynucleotides of (1) and (2), peptides and proteins of (4), vectors of (3), Ab, cells of (6), or their fragments; (12) similar method for identifying (A) in which (B) are encoded by the polynucleotides of (2); and (13) method for preparing proteins and peptides of (4) by culturing cells of (6). ACTIVITY : Analgesic. No details of tests for analgesic activity are given. MECHANISM OF ACTION : Gene therapy; Inhibiting expression and/or activity of pain-associated gene products. No supporting data is available.